Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tocilizumab”

422 trials

Showing 20 of 422 results

Post-approval studies (Phase 4)Study completedNCT02573012
What this trial is testing

Study to Compare the Efficacy of Tocilizumab With or Without Glucocorticoid Discontinuation in Rheumatoid Arthritis Participants

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 314
Post-approval studies (Phase 4)Study completedNCT01715831
What this trial is testing

A Long-term Safety Extension Study of Tocilizumab in Brazilian Participants With Rheumatoid Arthritis (RA) Who Completed the Studies ML21530 and MA21488

Who this might be right for
Arthritis, Rheumatoid
Hoffmann-La Roche 26
Early research (Phase 1)Study completedNCT03135171
What this trial is testing

Trastuzumab and Pertuzumab in Combination With Tocilizumab in Subjects With Metastatic HER2 Positive Breast Cancer Resistant to Trastuzumab

Who this might be right for
Breast Cancer
University of Michigan Rogel Cancer Center 11
Large-scale testing (Phase 3)UnknownNCT04361032
What this trial is testing

Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, Associated With Standards Treatments in COVID-19 (+) Patients Hospitalized In Intensive Care in Tunisia

Who this might be right for
COVID19Intensive Care Unit
Abderrahmane Mami Hospital 260
Large-scale testing (Phase 3)Study completedNCT01044498
What this trial is testing

Tocilizumab in Combination With an Oral Contraceptive in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 46
Not applicableStudy completedNCT01670045
What this trial is testing

A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 43
Large-scale testing (Phase 3)Study completedNCT01655381
What this trial is testing

A Long-Term Extension Study of WA19926 on the Safety of Tocilizumab (RoActemra/Actemra) in Participants With Early Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 15
Early research (Phase 1)Study completedNCT04547062
What this trial is testing

Monocentric Phase 1 Study With Escalation of Doses of Tocilizumab in Combination With Chemotherapy (Idarubicin and Cytarabine) in Patients With Acute Myeloblastic Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia (AML)
Nantes University Hospital 12
Not applicableLooking for participantsNCT07006532
What this trial is testing

Treatment of Chronic Active Antibody Mediated Rejection With Tocilizumab

Who this might be right for
Kidney Transplant Rejection
Shahid Beheshti University of Medical Sciences 50
Testing effectiveness (Phase 2)Study completedNCT02767557
What this trial is testing

Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab in Pancreatic Cancer Patients

Who this might be right for
Unresectable Pancreatic Carcinoma
Herlev Hospital 147
Testing effectiveness (Phase 2)WithdrawnNCT02511067
What this trial is testing

Ranibizumab for Edema of the mAcula in Diabetes: Protocol 4 With Tocilizumab: The READ-4 Study

Who this might be right for
Diabetic Macular Edema
University of Nebraska
Not applicableStudy completedNCT01918267
What this trial is testing

U-Act-After: An Observational Study on Long-Term Efficacy of Tight Control RoActemra/Actemra (Tocilizumab) and/or Methotrexate in Patients With Early Rheumatoid Arthritis Who Have Participated in the U-Act-Early Study (ML22497)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 226
Not applicableStudy completedNCT04529863
What this trial is testing

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Tocilizumab vs Abatacept

Who this might be right for
Rheumatoid Arthritis
Brigham and Women's Hospital 30,432
Large-scale testing (Phase 3)Ended earlyNCT01665430
What this trial is testing

A Long-Term Extension Study to WA19926 (NCT01007435) of Tocilizumab in Participants With Early, Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 38
Post-approval studies (Phase 4)Ended earlyNCT01283971
What this trial is testing

RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-Inhibitor

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 96
Post-approval studies (Phase 4)Study completedNCT02034474
What this trial is testing

Tocilizumab as Add-On Treatment For Residual Positive, Negative, and Cognitive Symptoms of Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
New York State Psychiatric Institute 59
Testing effectiveness (Phase 2)Looking for participantsNCT05972135
What this trial is testing

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

Who this might be right for
Multiple Myeloma
SCRI Development Innovations, LLC 100
Large-scale testing (Phase 3)Study completedNCT01667471
What this trial is testing

A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Juvenile Idiopathic Arthritis Who Completed WA19977 Core Study

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 6
Large-scale testing (Phase 3)Study completedNCT01214733
What this trial is testing

RoActemra/Actemra (Tocilizumab) Plus DMARDs in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 30
Early research (Phase 1)Study completedNCT02097524
What this trial is testing

Single-dose Study to Describe the Pharmacodynamics (PD) and Safety of Sarilumab (REGN88/SAR153191) and Tocilizumab in Adults With Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Regeneron Pharmaceuticals 105
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation